Susquehanna International Group, LLP 180 Life Sciences Corp. Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.12 - $1.31 $17,608 - $192,226	-146,738 Reduced 90.28%	15,793 $11,000
Q2 2022 Aug 15, 2022	SELL	$0.81 - $2.53 $65,523 - $204,659	-80,893 Reduced 33.23%	162,531 $138,000
Q1 2022 May 16, 2022	SELL	$2.53 - $3.9 $242,222 - $373,386	-95,740 Reduced 28.23%	243,424 $630,000
Q4 2021 Feb 14, 2022	SELL	$3.27 - $6.38 $618,890 - $1.21 Million	-189,263 Reduced 35.82%	339,164 $1.32 Million
Q3 2021 Nov 15, 2021	BUY	$5.11 - $10.81 $2.24 Million - $4.75 Million	438,972 Added 490.72%	528,427 $2.86 Million

Q2 2021 Aug 11, 2021	BUY	$6.7 - $11.98 $599,348 - $1.07 Million	89,455 New	89,455 $895,000

Ticker ATNF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,698,900
Market Cap $61.1M
Description
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.